Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BDT & MSD Partners is a merchant bank and investment firm formed in 2023 from the merger of BDT & Company and MSD Partners. It provides advisory services and long-term capital to business owners, family offices, trusts, foundations, and strategic investors. The firm focuses on long-term investments across various sectors including consumer goods, hospitality, industrials, technology—and has made notable investments in healthcare media via MJH Life Sciences™ but does not itself develop therapeutics or medical technologies[1][2][7].
In June 2024 it ranked 36th among the world’s largest private equity firms by Private Equity International[2]. Its strategy emphasizes partnership with founder-led businesses.
The company does not have its own clinical pipeline; rather it invests in companies across multiple industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BDT & MSD Partners.